Glaukos Corp (GKOS.N)
19 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|71||2001||Independent Chairman of the Board|
|56||2002||President, Chief Executive Officer and Director|
|41||2017||Chief Financial Officer, Senior Vice President - Corporate Development|
|56||2017||Chief Commercial Officer and Chief Operating Officer|
|2017||Chief Medical Officer|
- BRIEF-Glaukos' Idose Travoprost Achieves Sustained IOP Reduction And Favorable Safety Profile In 12-Month Interim Cohort
- BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System
- BRIEF-Glaukos Announces Submission Of Pre-Market Approval Application For IStent Inject Trabecular Micro-Bypass
- BRIEF-Glaukos To Begin Randomized U.S. IDE Pivotal Clinical Trial For iStent SA System
- BRIEF-Glaukos Corp posts Q3 earnings per share $0.04